Scilex Holding Company

Scilex Holding Companyverified

SCLX

Price:

$8.5

Market Cap:

$72.18M

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2021-03-05

Stock Exchange

NASDAQ

Ticker

SCLX

The Enterprise Value as of June 2026 (TTM) for Scilex Holding Company (SCLX) is 175.18M

According to Scilex Holding Company’s latest financial reports and current stock price. The company's current Enterprise Value is 175.18M. This represents a change of -13.73% compared to the average of 203.06M of the last 4 quarters.

Scilex Holding Company (SCLX) Historical Enterprise Value (quarterly & annually)

How has SCLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Scilex Holding Company over the last ten years is 619.07M. The current 175.18M Enterprise Value has changed 2.73% with respect to the historical average. Over the past ten years (40 quarters), SCLX's Enterprise Value was at its highest in in the June 2021 quarter at 1.70B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

619.07M

Median

390.34M

Minimum

0

Maximum

1.52B

Scilex Holding Company (SCLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Scilex Holding Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 1.52B

Minimum Annual Increase = -64.54%

Minimum Annual Enterprise Value = 0

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025262.20M89.44%
2024138.41M-64.54%
2023390.34M-27.01%
2022534.76M-63.97%
20211.48B-2.58%
20201.52BInfinity%

Scilex Holding Company (SCLX) Average Enterprise Value

How has SCLX Enterprise Value performed in the past?

The current Enterprise Value of Scilex Holding Company (SCLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

263.65M

5-year avg

561.99M

10-year avg

619.07M

Scilex Holding Company (SCLX) Enterprise Value vs. Peers

How is SCLX’s Enterprise Value compared to its peers?

Scilex Holding Company’s Enterprise Value is less than Opus Genetics, Inc. (294.81M), greater than Acumen Pharmaceuticals, Inc. (105.89M), greater than Citius Oncology, Inc. (62.91M), greater than Inovio Pharmaceuticals, Inc. (41.37M), greater than Incannex Healthcare Limited (-28511762.00), greater than Seer, Inc. (70.28M), less than Agenus Inc. (406.89M), greater than Lucid Diagnostics Inc. (97.21M), greater than VistaGen Therapeutics, Inc. (-27060355.00), greater than Alector, Inc. (127.45M),

CompanyEnterprise ValueMarket cap
294.81M$328.84M
105.89M$143.56M
62.91M$61.74M
41.37M$58.95M
-28511762.00$45.82M
70.28M$94.57M
406.89M$137.42M
97.21M$98.28M
-27060355.00$18.88M
127.45M$169.87M

Build a custom stock screener for Scilex Holding Company (SCLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scilex Holding Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scilex Holding Company (SCLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scilex Holding Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Scilex Holding Company's Enterprise Value?

What is the highest Enterprise Value for Scilex Holding Company (SCLX)?

What is the 3-year average Enterprise Value for Scilex Holding Company (SCLX)?

What is the 5-year average Enterprise Value for Scilex Holding Company (SCLX)?

How does the current Enterprise Value for Scilex Holding Company (SCLX) compare to its historical average?